MAP3K7 and hepatocellular carcinoma: Similarly, Kaplan-Meier plots showed that high co-expression of MAP3K7 and mTOR was associated with significantly shorter overall survival (Figure 6D), whereas it had no correlation with disease-free survival (Figure 6E), suggesting that the MAP3K7/mTOR axis is involved in tumor malignancy, but not recurrence, in patients with HCC.